| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1998;116:114-118
© 1998 Mosby, Inc.
Cardiopulmonary Support And Physiology |
Funded in part by the 3M/Surgical Infection Society Resident Research Fellowship (E. M. B.), the Thoracic Surgery Foundation for Research and Education Fellowship (E. M. B.), and the National Institutes of Health grants GM 46662 and T32 GM 07037 (T. H. P.).
Read at the Twenty-third Annual Meeting of The Western Thoracic Surgical Association, Napa, Calif., June 25-28, 1997.
Address for reprints: Edward D. Verrier, MD, Professor and Chief, Division of Cardiothoracic Surgery, University of Washington, 1959 Pacific Ave. N.E., Box 356310, Seattle, WA 98195.
Introduction: Interleukin-8 is thought to play a role in neutrophil activation and transcapillary migration into the interstitium. Because neutrophils are principal effector cells in acute myocardial ischemia-reperfusion injury, we postulated that the inhibition of interleukin-8 activity with a neutralizing monoclonal antibody directed against rabbit interleukin-8 (ARIL8.2) would attenuate the degree of myocardial injury encountered during reperfusion.
Methods: In New Zealand White rabbits, the large branch of the marginal coronary artery supplying most of the left ventricle was occluded for 45 minutes, followed by 2 hours of reperfusion. Fifteen minutes before reperfusion, animals were given an intravenous bolus of either 2 mg/kg of ARIL8.2 or 2 mg/kg anti–glycoprotein-120, an isotype control antibody that does not recognize interleukin-8. At the completion of the 120-minute reperfusion period, infarct size was determined.
Results: In the area at risk for infarction, 44.3% ± 4% of the myocardium was infarcted in the anti–glycoprotein-120 group compared with 24.8% ± 9% in the ARIL8.2 group (p < 0.005). In control animals, edema and diffuse infiltration of neutrophils were observed predominantly in the infarct zone and the surrounding area at risk. Tissue myeloperoxidase determinations did not differ significantly between groups, indicating that the cardioprotective effect of ARIL8.2 was independent of an effect on neutrophil infiltration.
Conclusions: A specific monoclonal antibody that neutralizes interleukin-8 significantly reduces the degree of necrosis in a rabbit model of myocardial ischemia-reperfusion injury.
This article has been cited by other articles:
|
|
 |
|
  S. Apostolakis, K. Vogiatzi, V. Amanatidou, and D. A. Spandidos Interleukin 8 and cardiovascular disease Cardiovasc Res, December 1, 2009; 84(3): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Frantz, J. Bauersachs, and G. Ertl Post-infarct remodelling: contribution of wound healing and inflammation Cardiovasc Res, February 15, 2009; 81(3): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle High-Dose Insulin Therapy Attenuates Systemic Inflammatory Response in Coronary Artery Bypass Grafting Patients Ann. Thorac. Surg., July 1, 2008; 86(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Skov, F. J. Beurskens, C. O. C. Zachariae, S. Reitamo, J. Teeling, D. Satijn, K. M. Knudsen, E. P. J. Boot, D. Hudson, O. Baadsgaard, et al. IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis J. Immunol., July 1, 2008; 181(1): 669 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhai, X.-d. Shen, W. W. Hancock, F. Gao, B. Qiao, C. Lassman, J. A. Belperio, R. M. Strieter, R. W. Busuttil, and J. W. Kupiec-Weglinski CXCR3+CD4+ T Cells Mediate Innate Immune Function in the Pathophysiology of Liver Ischemia/Reperfusion Injury J. Immunol., May 15, 2006; 176(10): 6313 - 6322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dawn and R. Bolli HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H522 - H524. [Full Text] [PDF]
|
|
|
|
|
|
R. Ockaili, R. Natarajan, F. Salloum, B. J. Fisher, D. Jones, A. A. Fowler III, and R. C. Kukreja HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H542 - H548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brickson, L. L. Ji, K. Schell, R. Olabisi, B. St. Pierre Schneider, and T. M. Best M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury J Appl Physiol, September 1, 2003; 95(3): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pye, F. Ardeshirpour, A. McCain, D. A. Bellinger, E. Merricks, J. Adams, P. J. Elliott, C. Pien, T. H. Fischer, A. S. Baldwin Jr., et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H919 - H926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wan and A. P. C. Yim Tai Ji: The law of inflammatory response J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1071 - 1073. [Full Text]
|
|
|
|
|
|
P. Menasche The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2260 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miura, X. Fu, Q.-W. Zhang, D. G. Remick, and R. L. Fairchild Neutralization of Gro{alpha} and Macrophage Inflammatory Protein-2 Attenuates Renal Ischemia/Reperfusion Injury Am. J. Pathol., December 1, 2001; 159(6): 2137 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Erlich, E. M. Boyle, J. Labriola, J. C. Kovacich, R. A. Santucci, C. Fearns, E. N. Morgan, W. Yun, T. Luther, O. Kojikawa, et al. Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation Am. J. Pathol., December 1, 2000; 157(6): 1849 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shimamoto, S. Kanemitsu, K. Fujinaga, M. Takao, K. Onoda, T. Shimono, K. Tanaka, H. Shimpo, and I. Yada Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass Ann. Thorac. Surg., January 1, 2000; 69(1): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wan, J.-L. LeClerc, M. Antoine, J.-M. DeSmet, A. P.C. Yim, and J.-L. Vincent Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study Ann. Thorac. Surg., October 1, 1999; 68(4): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wan and A. P.C. Yim Cytokines in myocardial injury: impact on cardiac surgical approach Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S107 - S111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wan, M. B. Izzat, T. W. Lee, I. Y.P. Wan, N. L.S. Tang, and A. P.C. Yim Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury Ann. Thorac. Surg., July 1, 1999; 68(1): 52 - 56. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
